Literature DB >> 4404395

Antagonism of noradrenaline and histamine by desipramine in the isolated artery of the rabbit ear.

M W McCulloch, D F Story.   

Abstract

1. The effects of desipramine (DMI) were examined on the vasoconstrictor responses of the isolated perfused artery of the rabbit ear to noradrenaline (NA) and to histamine. Innervated and sympathetically denervated arteries were used.2. In innervated arteries, DMI in concentrations of 1 x 10(-8) to 1 x 10(-7)M enhanced the responses to NA; higher concentrations reduced the responses. In sympathetically denervated arteries, DMI caused only reduction of the responses to NA.3. Responses to histamine were reduced by DMI in both innervated and denervated arteries. DMI was considerably more potent as an antagonist of histamine than of noradrenaline.4. The reduction by DMI of the responses to NA and histamine in both innervated and denervated arteries was associated with a parallel shift to the right of the concentration-response curves of the agonist and a depression of the maximal response. These effects of DMI were reversible.5. Analysis of the data by the method of Arunlakshana & Schild (1959) showed the following: the antagonism of the action of NA by DMI on denervated arteries fulfilled the requirements for competitive antagonism; antagonism of the action of NA on innervated arteries was not competitive; antagonism of the actions of histamine on innervated and denervated arteries was not competitive.6. It is suggested that DMI antagonizes the action of NA and histamine on the perfused artery of the rabbit ear in two ways: (i) reversible specific antagonism which is competitive for NA and not competitive for histamine; (ii) reversible non-specific antagonism which is non-competitive for both agonists.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4404395      PMCID: PMC1666114          DOI: 10.1111/j.1476-5381.1972.tb06856.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  INFLUENCE OF IMIPRAMINE AND RELATED PSYCHOACTIVE AGENTS ON THE EFFECT OF 5-HYDROXYTRYPTAMINE AND CATECHOLAMINES ON THE CAT NICTITATING MEMBRANE.

Authors:  E B SIGG; L SOFFER; L GYERMEK
Journal:  J Pharmacol Exp Ther       Date:  1963-10       Impact factor: 4.030

2.  Effects of desipramine and cocaine on sympathetic responses in the pithed rat.

Authors:  A B Glover; M W McCulloch
Journal:  J Pharm Pharmacol       Date:  1970-10       Impact factor: 3.765

3.  Effect of desipramine on the depolarized isolated renal artery.

Authors:  P Hrdina; S Garattini
Journal:  J Pharm Pharmacol       Date:  1967-10       Impact factor: 3.765

4.  The assay of catecholamines released into the circulation of the guinea-pig by angiotensin.

Authors:  P J Piper; J R Vane
Journal:  J Physiol       Date:  1967-01       Impact factor: 5.182

5.  Some observations on the adrenergic blocking activity of desipramine and amitriptyline on aortic strips of rabbits.

Authors:  A Scriabine
Journal:  Experientia       Date:  1969-02-15

6.  Studies on the peripheral pharmacology of fenazoxine, a potential antidepressant drug.

Authors:  J R Bassett; K D Cairncross; N B Hacket; M Story
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  Studies on the mechanism of the inhibitory effect of desipramine (DMI) on vascular smooth muscle contraction.

Authors:  P D Hrdina; G M Ling
Journal:  J Pharmacol Exp Ther       Date:  1970-06       Impact factor: 4.030

9.  Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues.

Authors:  J AXELROD; L G WHITBY; G HERTTING
Journal:  Science       Date:  1961-02-10       Impact factor: 47.728

10.  Demethylimipramine (desipramine), an alpha-adrenergic blocking agent.

Authors:  R K Turker; P A Khairallah
Journal:  Experientia       Date:  1967-04-15
View more
  9 in total

1.  Investigation of the prejunctional alpha2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens.

Authors:  A Lavelle; V Honner; J R Docherty
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness.

Authors:  C de White; R B Royds; P Turner
Journal:  Postgrad Med J       Date:  1974-12       Impact factor: 2.401

3.  Comparison of the effects of desipramine on noradrenaline- and methoxamine-evoked venoconstriction in man.

Authors:  A H Abdelmawla; R W Langley; E Szabadi; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  1995-11       Impact factor: 4.335

4.  Relaxant effects of antidepressants on human isolated mesenteric arteries.

Authors:  J M Vila; P Medina; G Segarra; P Lluch; F Pallardó; B Flor; S Lluch
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

5.  Mechanism of action of dopamine on the guinea-pig gastro-oesophageal junction in vitro.

Authors:  B Cox; C Ennis
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

6.  Effects of imipramine and desipramine on responses of single cortical neurones to noradrenaline and 5-hydroxytryptamine.

Authors:  C M Bradshaw; M H Roberts; E Szabadi
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

7.  The effect of some antidepressants on prejunctional muscarinic receptors on the sympathetic nerves of the isolated rabbit ear artery.

Authors:  Y H Kwok; F Mitchelson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000

8.  pKI values of prazosin and idazoxan for receptors stimulated by neuronally released transmitter in the epididymal portion of rat isolated vas deferens.

Authors:  D Mackay; M Kengatharan
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

9.  Comparison of the responses of single cortical neurones to tyramine and noradrenaline: effects of desipramine.

Authors:  P Bevan; C M Bradshaw; R Y Pun; N T Slater; E Szabadi
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.